Cataract and Diabetic macular edema: What should I do?
|
|
- Beatrice Kennedy
- 5 years ago
- Views:
Transcription
1 Cataract and Diabetic macular edema: What should I do? Irini Chatziralli Ophthalmic Surgeon, University Scholar 2 nd Department of Ophthalmology, University of Athens (Director: Prof P. Theodossiadis)
2 Honoraria: Novartis, Boehringer Ingelheim Travel grants: Novartis, Boehringer Ingelheim, Allergan, ARVO foundation Advisory Board: Novartis
3 Cataract surgery target Improve visual function and contrast sensitivity Ability to monitor the disease
4 DIABETIC MACULAR EDEMA The most common cause of visual loss in patients with diabetes mellitus. Patients with DME are at an increased risk for cataract. In cataract patients, DME is found in about 1-3%. Both cataract and DME have common risk factors Inflammation Breakdown of blood-retinal barrier Metabolic factors Common symptom Reduced visual acuity Becker et al. Eye 2018 Feb 1 (in press)
5 Questions What is the pre-assessment of patients with DME and coexisting cataract? Should patients with DME be operated for cataract surgery? And when? Do they benefit from surgery or there is deterioration? Is any prophylaxis needed pre-, intra- or post-operatively? What is the management postoperatively in such patients?
6 Accurate diathlasis-pinhole Slit-lamp examination to define type and grade of cataract, as well as the degree of visual deterioration that can be attributed to cataract or DME Retinal imaging (OCT, FA,U/S) for assessment of DME and potential ischemia Pre-assessment of cataract patient with coexisting DME Good glycaemic control very important!!!! Control of systemic factors
7 JAMA 2005 Patients with poorly controlled disease have been linked with a higher risk for postoperative macular edema. The presence of DME before surgery is also an important risk factor for macular thickness increase postoperatively.
8 JCRS 2006 Prospective study 132 patients with DM Phacoemulsification in one eye Control eye= non-operated eye Contrary to ETDRS study, uneventful phacoemulsification does not affect the progression of DR Same progression between operated and non-operated eyes Factors related to progression of DR were HbA1c and duration of DM Uneventful phacoemulsification has no impact in DME
9 Jama Ophthamol 2010 Phacoemulsification and advanced cataract surgery modalities do not progress DME and DR. Early phacoemulsification offers optimal posterior pole visualization and monitoring of the disease. Intravitreal agents (anti-vegf or steroids) may be useful as an adjunct.
10 Retina 2015
11 BJO 2017 The rate of developing DME was 5.3% in the year after surgery. The risk of DME increased sharply after surgery, peaking in the 3-6 months postoperatively. Risk was associated with preoperative grade of DR.
12 Ophthalmology eyes with DM Postoperative macular edema in 4.04% The risk was higher in the presence of any DR and rose proportionately with increasing severity of DR
13 Should patients with DME be operated for cataract surgery? Do they benefit from surgery or there is deterioration? Controversial literature especially before advances in machines and techniques for cataract surgery. Patients with concurrent DME and cataract can be operated, especially in cases with dense cataract, so as to be able to perform safe fundoscopy. Patients benefit from surgery. Evidence shows that uneventful cataract surgery do not progress DME in the majority of patients. The risk of DME progression increases 3-6 months postoperatively and is associated with previous grade of DR/DME.
14 Retina 2009 Intravitreal bevacizumab immediately after phacoemulsification was found to prevent exacerbation of macular edema in diabetic patients. This effect seems to hold in the short term results of 6 months. BUT, the study included patients without prior DME and only NPDR. Retina 2012 Intravitreal ranibizumab was found not to change central macular thickness after cataract surgery in patients with DME. No worsening of DME. Improvement of visual acuity due to removal of cataract.
15 J Ophthalmol eyes with advanced cataract and DME Uneventful phacoemulsification 3 groups: RAN 2 weeks preoperatively RAN intraoperatively RAN 2 weeks postoperatively Intra- and post-operative RAN seems to be more effective than preoperative The treatment still needs to be continued after surgery!
16 Clin Exp Ophthalmol eyes with cataract and DME Prospective randomized study IVTA vs bevacizumab Both were effective in VA improvement Only IVTA results in a sustained reduction in CMT
17 EJO 2015 Retina 2017 One single Ozurdex seems to be sufficient if given postoperatively in patients with DR, preventing the progression of DME Combined cataract surgery and intravitreal dexamethasone (Ozurdex) seems safe and effective in patients with DME and cataract Ozurdex can be performed at the time of surgery as well in such patients Another therapeutic potential intravitreal triamcinolone with good anatomic and functional results Campos et al. J Ocul Pharmacol Ther 2014 Panozzo et al. European J Ophthalmol 2016
18 Use of NSAID drops (ketorolac or nepafenac) postoperatively reduces the risk of ME in patients without previous history of DME or with DR Regimen: one drop four times/day for 15 days
19 Ophthalmology 2017 Nepafenac 0.3% once daily (starting one day before surgery and for 90 days postoperatively) was effective in preventing postoperative ME in patients with diabetic retinopathy
20 Is any prophylaxis needed pre-, intra- or post-operatively? Postoperative management In patients with DM (especially where OCT was not done because of cataract preoperatively), it should be done during the first postoperative week to assess macular thickness! Close follow-up to evaluate promptly CME Prophylactic treatment with NSAIDs There is evidence that intravitreal anti-vegf, triamcinolone or dexamethasone implant are effective for DME with concurrent cataract either intra- or post-operatively
21 WHAT SHOULD I DO In diabetic cataract patients and DME.? can be operated.good glycaemic control..stabilization of DME prior to surgery at least 3-6 months...use of anti-vegf/steroid intravitreally in combination with cataract surgery Some authors suggest to use anti-vegf 8-15 days prior to surgery for optimal result!.prophylactic treatment with NSAIDs.close monitoring for DME progression and differentiation from Irvine-Gass
22 Thank you!
The Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR
The Diabetic Retinopathy Clinical Research Network Management of DME in Eyes with PDR 1 What Has Been Learned? Diabetic Retinopathy Treatment Protocol F: Results suggest that clinically meaningful differences
More informationSurgery in patients with uveitis. Lyndell Lim and Anthony Hall
Surgery in patients with uveitis Lyndell Lim and Anthony Hall Disclosures Off label treatments Paid advisory board Bayer Paid research support Allergan (makers of Ozurdex) Paid research support B and L
More informationDiabetic Macular Oedema To treat or not to treat?
Diabetic Macular Oedema To treat or not to treat? Ms Ranjit Sandhu MBBS MRCOphth MD FRCOphth Consultant Ophthalmic Surgeon Cataract Surgery, Medical Retina & Uveitis The Luton and Dunstable University
More informationRecalcitrant Diabetic Macular Oedema: Therapeutic Options
December 2007 A. Giridhar et al. - Recalcitrant DME 451 CONSULTATION S E C T I O N Recalcitrant Diabetic Macular Oedema: Therapeutic Options Dr. Cyrus M Shroff 1, Dr. N S Muralidhar 2, Dr. R Narayanan
More informationDiabetic maculopathy 11/ An update on. Miss Vasuki Sivagnanavel
Miss Vasuki Sivagnanavel Consultant Ophthalmologist An update on Diabetic maculopathy Despite advances in the management of diabetes, diabetic retinopathy is already the commonest cause of blindness among
More informationNew Developments in the treatment of Diabetic Retinopathy
New Developments in the treatment of Diabetic Retinopathy B. Jeroen Klevering University Medical Centre Nijmegen - The Netherlands Topics Management of diabetic retinopathy Interventions a. primary (prevention)
More informationOptometric Postoperative Cataract Surgery Management
Financial Disclosures Optometric Postoperative Cataract Surgery Management David Dinh, OD Oak Cliff Eye Clinic Dallas Eye Consultants March 10, 2015 Comanagement Joint cooperation between two or more specialists
More informationDiabetic Retinopathy: Recent Advances in Treatment and Treatment Approaches
Diabetic Retinopathy: Recent Advances in Treatment and Treatment Approaches Dr. David Wong Associate Professor Retina Specialist, Department of Ophthalmology & Vision Sciences, University of Toronto, Canada
More informationDiabetic Retinopatathy
Diabetic Retinopatathy Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Arctic DX Macula Risk Advanced
More informationDiabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina
Diabetic Retinopathy: Managing the Extremes J. Michael Jumper, MD West Coast Retina Case 1: EC 65 y.o. HM No vision complaints Meds: Glyburide Metformin Pioglitazone Va: 20/20 OU 20/20 Case 2: HS 68 y.o.
More informationOriginal Article. Authors
Original Article APMC-303 Efficacy of Intra-Vitreal Bevacizumab Combined with Phaco- Emulsification in the Prophylaxis of Macular Edema in Patients with Non-Proliferative Diabetic Retinopathy Muhammad
More informationA retrospective nonrandomized study was conducted at 3
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine 1, Seoul, Korea Hangil Eye Hospital 2, Incheon, Korea Seoul National University Bundang Hospital 3, Seongnam,
More informationEFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA
Basrah Journal Of Surgery EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA Salah Zuhair Abed Al-Asadi MB,ChB, FICMS, Lecturer, Department of Surgery, College
More informationProphylaxis of Macular edema with Peroperative Intravitreal Bevacizumab in Diabetic Retinopathy Patients Undergoing Phacoemulsification
Original Article Prophylaxis of Macular edema with Peroperative Intravitreal Bevacizumab in Diabetic Retinopathy Patients Undergoing Phacoemulsification Sidra Jabeen, Rizwan Khan, Ali Raza Pak J Ophthalmol
More informationPast ocular history. DME Case 1. Patient presents blurred VA. Hemoglobin A1c 11.5% -- patient states sugars have not been in good control
Past ocular history Patient presents blurred VA DME Case 1 Hemoglobin A1c 11.5% -- patient states sugars have not been in good control PDR with macular edema OU Rishi Singh MD Cleveland Clinic OD OS 1
More information1. Introduction. Correspondence should be addressed to Alfredo Niro;
Hindawi Ophthalmology Volume 2017, Article ID 4896036, 7 pages https://doi.org/10.1155/2017/4896036 Clinical Study Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex ) in Diabetic
More informationTargeting Inflammation in Diabetic Macular Edema: From Basic Science to Clinical Trials to Clinical Practice
Targeting Inflammation in Diabetic Macular Edema: From Basic Science to Clinical Trials to Clinical Practice Baruch D Kuppermann, MD, PhD Professor of Ophthalmology and Biomedical Engineering Director,
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More informationThe role of perioperative nonsteroidal anti-inflammatory drugs use in cataract surgery
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 18, Issue 1 Ser. 15 (January. 2019), PP 23-27 www.iosrjournals.org The role of perioperative nonsteroidal
More information1/25/2018. Case Management Strategies in Diabetic Retinopathy. Case Study #1: Severe DME. DDOS: 3/31/2016 Va 20/400. Disclosures
Case Management Strategies in Diabetic Retinopathy Disclosures No financial conflict of interest Will discuss off label use of intraocular Bevacizumab (Avastin) for Diabetic Retinopathy Sundeep Dev, MD
More informationPersistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
9:30 AM Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment Lee Jampol, MD OBJECTIVE To assess subsequent visual and anatomic outcomes of eyes with
More informationDexamethasone implant in diabetic macular edema in real-life situations
(2016) 30, 426 430 2016 Macmillan Publishers Limited All rights reserved 0950-222X/16 www.nature.com/eye CLINICAL STUDY 1 Smt. Kanuri Santhamma Retina Vitreous Centre, L.V. Prasad Institute, Hyderabad,
More informationFLUOCINOLONE ACETONIDE: STEROID LONG ACTING
FLUOCINOLONE ACETONIDE: STEROID LONG ACTING Giuseppe Querques, MD PhD Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita Salute San Raffaele, Milan, Italy Financial Disclosure ADVISORY
More informationCOMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY
Original Article COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY Aggarwal Somesh V 1, Shah Sonali N 2, Bharwada Rekha
More informationCase Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema V Swetha E Jeganathan 1,2 * and Karen Madill 3 1 Department of Ophthalmology,
More informationORIGINAL RESEARCH ARTICLE
EJO ISSN 1120-6721 Eur J Ophthalmol 2017; 27 (3): 357-362 DOI: 10.5301/ejo.5000929 ORIGINAL RESEARCH ARTICLE Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal
More informationEyes on Diabetics: How to Avoid Blindness in Diabetic Patient
Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient Rova Virgana FK Unpad Pusat Mata Nasional RS Mata Cicendo Bandung Eye Center (Hospital and Clinic) PIT IDI Jabar 2018 Keys Facts from WHO
More informationEvaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2011;25(4):238-242 DOI: 10.3341/kjo.2011.25.4.238 Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery Original
More informationABSTRACT INTRODUCTION
DOI 10.1007/s40123-017-0114-6 ORIGINAL RESEARCH Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective
More informationCME in the Phaco era Myth or Reality. Nicholas Lee Hillingdon & Western Eye
CME in the Phaco era Myth or Reality Nicholas Lee Hillingdon & Western Eye Scope History Incidence Pathogenesis Treatments None Steroids Acular Yellox Diamox Anti-vegf Prevention Audit Irvine Gass Syndrome
More informationBromfenac eyedrops in the treatment of diabetic macular edema: a pilot study
EJO ISSN 1120-6721 Eur J Ophthalmol 2017; 27 (3): 326-330 DOI: 10.5301/ejo.5000888 Original Research Article Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study Antonio Pinna,
More informationResearch Article http://www.alliedacademies.org/clinical-ophthalmology-and-vision-science/ A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal
More informationIs OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema
Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Ayman M Khattab MD, FRCS Professor of Ophthalmology Cairo University Diabetic Macular Edema (DME) Diabetic macular
More informationCase Report Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
Case Reports in Ophthalmological Medicine, Article ID 231913, 5 pages http://dx.doi.org/10.1155/2014/231913 Case Report Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone
More informationDiabetic Macular Edema Treatment in the 21st Century
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationOCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationParadigm Shift in the treatment of Diabetic Retinopathy. Haytham I. S. Salti, MD Associate Professor
Paradigm Shift in the treatment of Diabetic Retinopathy Haytham I. S. Salti, MD Associate Professor Disclosure No financial interests related to the subject matter of this talk This presentation includes
More informationILUVIEN IN DIABETIC MACULAR ODEMA
1 ILUVIEN IN DIABETIC MACULAR ODEMA Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham bars conference 2104 1 2 Declaration of interest I have sat on Advisory boards for
More informationJay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington
Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington I Jay M. Haynie, OD, FAAO have received honoraria from the following companies: Reichert Technologies Notal Vision Carl Zeiss Meditec
More informationStudy of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema
Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali
More informationEU Regulatory workshop Ophthalmology clinical development and scientific advice. Industry view on DME and macular edema secondary to RVO
EU Regulatory workshop Ophthalmology clinical development and scientific advice. Industry view on DME and macular edema secondary to RVO Yehia Hashad, M.D. Vice President and Global Therapeutic Area Head
More informationRetinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)
Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England (Royal Victoria Infirmary, Sunderland Eye Infirmary, James Cook University Hospital, Darlington Memorial Hospital, University Hospital
More informationIntravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis
105 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More informationDiabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Clinical Research Network Short-term Evaluation of Combination Corticosteroid+Anti- VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
More informationFirst postoperative day review after uneventful phacoemulsification cataract surgery: Is it necessary?
Chatziralli et al. BMC Research Notes 2012, 5:333 RESEARCH ARTICLE Open Access First postoperative day review after uneventful phacoemulsification cataract surgery: Is it necessary? Irini P Chatziralli
More informationClinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME
Clinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME Ophthalmology Innovation Summit @ AAO, October 25 2018 Megan Baldwin PhD, CEO & Managing Director Disclaimer Investment
More informationROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS
ORIGINAL ARTICLE ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS Aggarwal Somesh VP 1, Shah Sonali N 2, Bharwada Rekha M 3,
More informationClinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME
Clinical results of OPT-302 (VEGF-C/D Trap ) Combination Treatment in namd and DME Ophthalmology Innovation Summit @ AAO, October 25 2018 Megan Baldwin PhD, CEO & Managing Director Disclaimer Investment
More informationnepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd
nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationDiabetic Retinopathy Update 2017
Diabetic Retinopathy Update 2017 Basis for DR management standards for past 40 years Diabetic Retinopathy Study (DRS) 1971-1989 and Early Treatment of Diabetic Retinopathy Study (ETDRS) 1979-1990 Sundeep
More informationLong-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant
Ophthalmol Ther (2015) 4:51 58 DOI 10.1007/s40123-015-0028-0 CASE REPORT Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant Thomas Bertelmann
More informationCSME BCVA. OCT Bevacizumab CMT CMT BCVA. BCVA LogMAR. p CMT NPDR PDR PDR. Bevacizumab PDR FDA. Ranibizumab. Bevacizumab.
email: rezaj76@yahoo.com Bevacizumab FDA mg Ranibizumab - Bevacizumab NPDR PDR PDR PDR CSME FAZFA BCVA CMT OCT Bevacizumab BCVA CMT BCVA LogMAR p CMT p CSME CRVO CSME BRVO CRVOBRVO (fovea avascular zone)
More informationPROGRESSION OF DIABETIC RETINOPATHY FOLLOWING CATARACT SURGERY
PROGRESSION OF DIABETIC RETINOPATHY FOLLOWING CATARACT SURGERY Yayan Heryanto, Iwan Sovani, Arief Kartasasmita, Erwin Iskandar, Djonggi Panggabean. Dept. of Ophthalmology Medical Faculty Unpad, Cicendo
More informationVankadara Naga Suresh * 1, Rama Vadapalli 2. Online Access and Article Informtaion. Original Research Article
Original Research Article Effect of Prophylactic Bromfenac 0.07% on Cystoid Macular Edema Assessed using Optical Coherence Tomography Quantification of Total Macular Volume after Cataract Surgery Vankadara
More informationCombination Treatment of Diabetic Macular Edema with Anti-Vascular Endothelial Growth Factor and Steroids: Analysis of DRCR.
REVIEW ARTICLE Combination Treatment of Diabetic Macular Edema with Anti-Vascular Endothelial Growth Factor and Steroids: Analysis of DRCR.net Protocol U Cindy Ung 1, Kareem Moussa 1, Yoshihiro Yonekawa
More informationRama Vadapalli * 1, Vankadara Naga Suresh 2. Online Access and Article Informtaion. Original Research Article
Original Research Article An Interventional Follow up Study to Determine the Effect of Nepafenac 0.1% in Macular thickness in Patients who had Undergone Cataract Surgery as Determined By OCT Rama Vadapalli
More informationINTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76
INTERPRETING THICKNESS CHANGES IN THE DIABETIC MACULA: THE PROBLEM OF SHORT- TERM VARIATION IN OPTICAL COHERENCE TOMOGRAPHY MEASURED MACULAR THICKENING (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS) BY
More informationKyungmin Lee, Heeyoung Chung, Youngsuk Park, Joonhong Sohn. HanGil Eye Hospital, Incheon, Korea
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2014;28(4):298-305 http://dx.doi.org/10.3341/kjo.2014.28.4.298 Original Article Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor or
More informationDexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2017;31(2):108-114 https://doi.org/10.3341/kjo.2017.31.2.108 Original Article Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory
More informationPhiladelphia College of Osteopathic Medicine. Heather Bladek Philadelphia College of Osteopathic Medicine,
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2014 In Adult Patients With Diabetic Macular
More informationMacular edema (ME) is the most common
MANAGEMENT OF RETINAL VEIN OCCLUSIONS * Peter A. Campochiaro, MD ABSTRACT Macular edema (ME) is the most common cause of reduced vision in patients with retinal vein occlusions (RVOs). The primary cause
More informationNavilas Clinical Results: Diabetic Macular Edema Introducing a Better Treatment Paradigm for Patients and Physicians
Navilas Clinical Results: Diabetic Macular Edema Introducing a Better Treatment Paradigm for Patients and Physicians 16 % Injection-free after loading phase 65 % Injection-free after loading phase Navilas
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Last Review: September 20 Next Review: September 2017 Related Policies 9.03.21 Aqueous Shunts for Glaucoma Intravitreal Corticosteroid Implants Summary An intravitreal implant
More informationFA Conference. Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences
FA Conference Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences Patient Presentation CC: (sent by optometrist) Blurry/foggy vision HPI: 62 yo
More informationEfficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
AOP*** 1 Original Article Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion Rasha I Ali1, Kapil G Kapoor 1,2, Adeel N Khan 1, Syed K Gibran 1 Purpose: To
More informationNew Insights on Treating Diabetic Retinopathy & Diabetic Macular Edema from the 2018 AAO Meeting
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationThe effect of a single intravitreal implantation of dexamethasone on the fellow eye in bilateral non-infectious uveitis case report
European Review for Medical and Pharmacological Sciences The effect of a single intravitreal implantation of dexamethasone on the fellow eye in bilateral non-infectious uveitis case report J. CISZEWSKA,
More informationPREDICTORS OF VISUAL RESPONSE TO INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF DIABETIC MACULAR EDEMA
ORIGINAL ARTICLE PREDICTORS OF VISUAL RESPONSE TO INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF DIABETIC MACULAR EDEMA Sunny Kumar Gupta 1,*, Ishan Yadav 2, Sujit Deshmukh 3, Rajendra P Maurya 4, V P Singh
More informationCharles C. Wykoff MD PhD Rahul N. Khurana MD
HDWallpapers Suprachoroidal Triamcinolone Acetonide with & without Intravitreal Aflibercept for DME: Results of the 6 Month Prospective Phase 1/2 Hulk trial Blanton Eye Institute Charles C. Wykoff MD PhD
More informationTHE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION
THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION MOESTIDJAB DEPARTMENT OF OPHTHALMOLOGY SCHOOL OF MEDICINE AIRLANGGA UNIVERSITY DR SOETOMO HOSPITAL SURABAYA INTRODUCTION
More informationANTI-VEGF THERAPY FOR DIABETIC MACULAR EDEMA
January/February 2015 Supplement to ANTI-VEGF THERAPY FOR DIABETIC MACULAR EDEMA A roundtable discussion with Franck Fajnkuchen, MD, and Paolo Lanzetta, MD Case report by Paolo Lanzetta, MD The answers
More informationMarie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham. bars 2014
Marie Tsaloumas Consultant Ophthalmic Surgeon Queen Elizabeth Hospital, Birmingham bars 2014 Declaration of interest I have sat on Advisory boards for Novartis and Bayer Involved in Novartis sponsored
More informationVISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT
The Professional Medical Journal DOI: 10.17957/TPMJ/16.2856 ORIGINAL PROF-2856 VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT 1. MBBS.FCPS Assistant Professor Ophthalmology Independent
More informationOphthalmology Macular Pathways
Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological
More informationDiabetic and the Eye: An Introduction
Diabetic and the Eye: An Introduction Lawrence Iu FRCSEd (Ophth), FCOphthHK, FHKAM (Ophthalmology) Department of Ophthalmology, Grantham Hospital & Queen Mary Hospital Background Diabetes mellitus (DM)
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health Technology Appraisal. Aflibercept for treating diabetic macular oedema.
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health Technology Appraisal Aflibercept for treating diabetic macular oedema Final scope Final remit/appraisal objective To appraise the clinical and cost
More informationDiabetic Retinopathy Clinical Research Network
Diabetic Retinopathy Clinical Research Network Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk Version 4.0 September 19, 2017 Anti-VEGF
More informationTreatment pathways for Intravitreal therapies in Diabetic Macular Oedema (DMO) Louise Downey Consultant Ophthalmologist MBChB BSc PhD FRCOphth
Treatment pathways for Intravitreal therapies in Diabetic Macular Oedema (DMO) Louise Downey Consultant Ophthalmologist MBChB BSc PhD FRCOphth Disclosures and acknowledgements Financial disclosures; Alcon,
More informationMedical Science. Research Paper. 2nd yr post graduate, Dept. Of Ophthalmology, SVS Medical College
Dr. A.Narasimha Rao Dr. N.Deepika Dr. D.Chandrakanth Reddy Dr. M. Vijaya Ramaraju ABSTRACT KEYWORDS Research Paper Medical Science Comparative Evaluation of the Anti- Inflammatory Effect of Topical 1 %
More informationIntravitreal Monotherapy with Bevacizumab and Triamcinolone Versus Combination Therapy in Recalcitiant Diabetic Macular Edema
Intravitreal Monotherapy with Bevacizumab and Triamcinolone Versus Combination Therapy in Recalcitiant Diabetic Macular Edema Meena Chakrabarti MS, DO, DNB Meena Chakrabarti MS, DO, DNB, Sonia Rani John
More informationA RETROSPECTIVE OBSERVATIONAL STUDY OF INTRAVITREAL OZURDEX IMPLANT IN TREATING MACULAR PERSISTEN EDEMA
A RETROSPECTIVE OBSERVATIONAL STUDY OF INTRAVITREAL OZURDEX IMPLANT IN TREATING MACULAR PERSISTEN EDEMA CRISTIAN TURLEA 1,MAGDALENA TURLEA 1,ILEANA ZOLOG 4, PAVEL FARCAS 2, ANDREI BRANCO TOMESCU 3 1 Department
More informationDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2017;31(5):394-401 https://doi.org/10.3341/kjo.2016.0109 Original Article Additive Effect of Oral Steroid with Topical Nonsteroidal Antiinflammatory
More informationORIGINAL ARTICLE. Introduction. June 2009 Kerala Journal of Ophthalmology 139
June 2009 Kerala Journal of Ophthalmology 139 ORIGINAL ARTICLE Intravitreal Monotherapy With Bevacizumab (IVB) and Triamcinolone Acetonide (IVTA) Versus Combination Therapy (IVB and IVTA) for Recalcitiant
More informationCorporate Medical Policy
Corporate Medical Policy Intravitreal Implant File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intravitreal_implant 11/2010 6/2017 6/2018 6/2017 Description of Procedure or Service
More informationFront Line Diabetic Retinopathy What Not to Miss and Why
Front Line Diabetic Retinopathy What Not to Miss and Why David M Brown MD FACS Clinical Professor of Ophthalmology Blanton Eye Institute, Houston Methodist Hospital Baylor College of Medicine Retina Consultants
More informationMoncef Khairallah, MD
Moncef Khairallah, MD Department of Ophthalmology, Fattouma Bourguiba University Hospital Faculty of Medicine, University of Monastir Monastir, Tunisia INTRODUCTION IU: anatomic form of uveitis involving
More informationOpthea Initiates OPT-302 Diabetic Macular Edema Clinical Trial
ASX and Media Release 3 January 2018 Opthea Initiates OPT-302 Diabetic Macular Edema Clinical Trial Melbourne, Australia; January 3 2018 Opthea Limited (ASX:OPT), a late stage biopharmaceutical company
More informationWe know diabetes is a common and growing problem as well as the leading cause
ebook A GAME-CHANGER IN DIABETIC RETINOPATHY Early diagnosis and management guidance using objective, functional vision testing. by STEVEN M. SILVERSTEIN, MD We know diabetes is a common and growing problem
More informationUveitis is a common cause of preventable blindness
Treatment of Uveitic Cystoid Macular Edema Three case reports discuss the management of inflammatory CME. BY PRANJAL THAKURIA, MD; AND C. STEPHEN FOSTER, MD Uveitis is a common cause of preventable blindness
More information84 Year Old with Rosacea
84 Year Old with Rosacea S/p tap and injection of intravitreal vancomycin, ceftazidime, dexamethasone Post-injection day#1 Va HM IOP 14 mmhg Post-injection week#3 BCVA 20/20-3 (plano +0.50 x 180) IOP 23
More informationSeong Joon Ahn *, Jooyoung Joung, Sang Hyup Lee and Byung Ro Lee *
Ahn et al. BMC Ophthalmology (2018) 18:310 https://doi.org/10.1186/s12886-018-0985-x CASE REPORT Open Access Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to
More informationControversies in the management of Irvine-Gass syndrome
Incorporating current trials and technology into clinical practice Controversies in the management of Irvine-Gass syndrome by Daniel F. Kiernan, MD Seenu M. Hariprasad Practical Retina Editor Cystoid macular
More informationVisual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes
March 2009 Raju K.V. et al. - Closed Globe Injuries 31 ORIGINAL ARTICLE Visual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes Dr. Mahesh G. MS DO DNB FRCSEd, Dr. A. Giridhar MS, Dr.
More informationEccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case Report
Ophthalmol Ther (2017) 6:391 395 DOI 10.1007/s40123-017-0113-7 CASE REPORT Eccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case
More informationOriginal Paper. Ophthalmic Res DOI: /
Original Paper Received: December 19, 216 Accepted: December 19, 216 Published online: February 9, 217 A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN
More informationResearch Article Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
Hindawi Publishing Corporation Journal of Ophthalmology Volume 2016, Article ID 9875741, 6 pages http://dx.doi.org/10.1155/2016/9875741 Research Article Differentiation between Good and Low-Responders
More informationResearch Article Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants
Ophthalmology Volume 2016, Article ID 6016491, 6 pages http://dx.doi.org/10.1155/2016/6016491 Research Article Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal
More informationAWMSG SECRETARIAT ASSESSMENT REPORT. Nepafenac (Nevanac ) 1 mg/ml eye drops, suspension. Reference number: 1509 FULL SUBMISSION
AWMSG SECRETARIAT ASSESSMENT REPORT Nepafenac (Nevanac ) 1 mg/ml eye drops, suspension Reference number: 1509 FULL SUBMISSION This report has been prepared by the All Wales Therapeutics and Toxicology
More informationPRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique
Injection Technique Quick-Reference Guide PRECISION PROGRAM Companion booklet for the Video Guide to Injection Technique Available at www.ozurdexprecisionprogram.com Provides step-by-step directions with
More information